Kingdon Capital Management’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,972,056
| Closed | -$2.47M | – | 92 |
|
|
2022
Q1 | $2.47M | Hold |
1,972,056
| – | – | 0.26% | 51 |
|
|
2021
Q4 | $2.29M | Hold |
1,972,056
| – | – | 0.26% | 53 |
|
|
2021
Q3 | $3.79M | Hold |
1,972,056
| – | – | 0.46% | 37 |
|
|
2021
Q2 | $4.62M | Hold |
1,972,056
| – | – | 0.53% | 41 |
|
|
2021
Q1 | $5.34M | Hold |
1,972,056
| – | – | 0.55% | 38 |
|
|
2020
Q4 | $4.77M | Buy |
1,972,056
+1,260,504
| +177% | +$3.05M | 0.52% | 34 |
|
|
2020
Q3 | $1.63M | Hold |
711,552
| – | – | 0.18% | 48 |
|
|
2020
Q2 | $1.64M | Hold |
711,552
| – | – | 0.15% | 41 |
|
|
2020
Q1 | $1.22M | Sell |
711,552
-21,498
| -3% | -$37K | 0.22% | 43 |
|
|
2019
Q4 | $1.52M | Buy |
733,050
+46,828
| +7% | +$96.9K | 0.23% | 38 |
|
|
2019
Q3 | $1.99M | Buy |
686,222
+20,000
| +3% | +$58K | 0.24% | 46 |
|
|
2019
Q2 | $2.61M | Buy |
+666,222
| New | +$2.61M | 0.26% | 53 |
|